Metabolic Strategies to Enhance the Toxicity of Nitric Oxide in Pathogens | AIChE

Metabolic Strategies to Enhance the Toxicity of Nitric Oxide in Pathogens


Title: Metabolic Strategies to Enhance the Toxicity of Nitric Oxide in Pathogens
Author: Mark P. Brynildsen
Nitric oxide (NO•) is an antimicrobial used by immunity to neutralize pathogens. The importance of NO• to immune function is evidenced by the many pathogens, including Mycobacterium tuberculosis, Neisseria meningitides, Vibrio cholerae, Salmonella enterica, and enterohemorrhagic Escherichia coli (EHEC), that depend on NO• detoxification to establish an infection1-7. Inhibitors of NO• defense systems are under investigation as next-generation antibiotics8,9, and direct delivery of NO• has shown potential for treating infections when antibiotics fail10-17. However, these efforts have been hampered by a narrow concentration window within which bacteria are neutralized and host cells remain unharmed, and a lack of effective agents that enhance NO• toxicity in pathogens9,14. A quantitative understanding of NO• cytotoxicity, and the adaptive responses mounted by bacteria would aid in identifying targets to sensitize pathogens toward host- or therapeutic-derived NO•. Due to the complexity of the NO• biochemical reaction network, where NO• directly reacts with Fe-S clusters, O2, and O2•-, and its autoxidation products (e.g., N2O3, ONOO-) damage thiols, tyrosine residues, and DNA bases18-
20, coupled with the metabolic requirements of NO• defense systems (e.g., NADH, ATP), computational approaches are required to understand how bacteria process and respond to NO• stress.

Here I will discuss our work on the construction, experimental validation, and systems-level exploration of a detailed kinetic model of NO• metabolism and stress in E. coli21. This model has provided accurate predictions of NO• distributions among its reactions pathways under both aerobic and microaerobic conditions, enabled the discovery of a novel kinetic dependency of a major NO• detoxification system, and most recently been used to systematically identify the mechanism by which deletion of a protease produces major defects in NO• detoxification.

Further, I will discuss how we have translated the model to EHEC, and used it to investigate NO•
control of virulence factor expression in this dangerous food-borne pathogen. These results demonstrate the utility of quantitative metabolic modeling to the study of NO• stress in bacteria, and further, identify novel targets that when inhibited sensitize bacteria toward NO•.
References
1 Kakishima, K., Shiratsuchi, A., Taoka, A. et al. (2007), Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages, Biochem Biophys Res Commun, 355, 587-591.
2 Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J. C. et al. (2003), The proteasome of
Mycobacterium tuberculosis is required for resistance to nitric oxide, Science, 302, 1963-
1966.
3 Kulasekara, B. R., Jacobs, M., Zhou, Y. et al. (2009), Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence, Infect Immun, 77, 3713-3721.
4 Shimizu, T., Tsutsuki, H., Matsumoto, A. et al. (2012), The nitric oxide reductase of enterohaemorrhagic Escherichia coli plays an important role for the survival within macrophages, Mol Microbiol, 85, 492-512.
5 Stern, A. M., Hay, A. J., Liu, Z. et al. (2012), The NorR regulon is critical for Vibrio cholerae resistance to nitric oxide and sustained colonization of the intestines, MBio, 3, e00013-00012.
6 Stevanin, T. M., Moir, J. W. & Read, R. C. (2005), Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa, Infect Immun, 73, 3322-3329.
7 Karlinsey, J. E., Bang, I. S., Becker, L. A. et al. (2012), The NsrR regulon in nitrosative stress resistance of Salmonella enterica serovar Typhimurium, Mol Microbiol, 85, 1179-
1193.
8 Bryk, R., Gold, B., Venugopal, A. et al. (2008), Selective killing of nonreplicating mycobacteria, Cell Host Microbe, 3, 137-145.
9 Helmick, R. A., Fletcher, A. E., Gardner, A. M. et al. (2005), Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin, Antimicrob Agents Chemother, 49, 1837-1843.
10 Sulemankhil, I., Ganopolsky, J. G., Dieni, C. A. et al. (2012), Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing, Antimicrob Agents Chemother, 56, 6095-6103.
11 Friedman, A. J., Blecher, K., Schairer, D. et al. (2011), Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide, 25,
381-386.
12 Friedman, A., Blecher, K., Sanchez, D. et al. (2011), Susceptibility of Gram-positive and
-negative bacteria to novel nitric oxide-releasing nanoparticle technology, Virulence, 2,
217-221.
13 Heilman, B. J., St John, J., Oliver, S. R. et al. (2012), Light-triggered eradication of Acinetobacter baumannii by means of NO delivery from a porous material with an entrapped metal nitrosyl, J Am Chem Soc, 134, 11573-11582.
14 Jones, M. L., Ganopolsky, J. G., Labbe, A. et al. (2010), Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices, Appl Microbiol Biotechnol, 88, 401-407.
15 Jones, M. L., Ganopolsky, J. G., Labbe, A. et al. (2010), A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis, Appl Microbiol Biotechnol, 87, 509-516.
16 Sun, B., Slomberg, D. L., Chudasama, S. L. et al. (2012), Nitric oxide-releasing dendrimers as antibacterial agents, Biomacromolecules, 13, 3343-3354.
17 Lu, Y., Slomberg, D. L., Sun, B. et al. (2013), Shape- and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods, Small, 9, 2189-2198.
18 Bowman, L. A., McLean, S., Poole, R. K. et al. (2011), The diversity of microbial responses to nitric oxide and agents of nitrosative stress close cousins but not identical twins, Adv Microb Physiol, 59, 135-219.
19 Lancaster, J. R., Jr. (2006), Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions, Chem Res Toxicol, 19, 1160-1174.
20 Lim, C. H., Dedon, P. C. & Deen, W. M. (2008), Kinetic analysis of intracellular concentrations of reactive nitrogen species, Chem Res Toxicol, 21, 2134-2147.
21 Robinson, J. L. & Brynildsen, M. P. (2013), A kinetic platform to determine the fate of nitric oxide in Escherichia coli, PLoS Comput Biol, 9, e1003049.